OraVerse

Dr. Smith is now offering OraVerse to patients who don’t want that lingering numbness after local anesthetics.  After administrating OraVerse, a patient can return to normal sensation twice as fast.  In clinical trials, and in our practice, patients have reported a return as quickly as 30 minutes after receiving OraVerse.

OraVerse is the first and only local anesthesia reversal agent that accelerates the return to normal sensation and function for patients who want to avoid the unwanted and unnecessary lingering soft tissue numbness following routine dental procedures.  The first-in-class product was officially launched in 2009 by the San Diego based company Novalar Pharmaceuticals, Inc.

The average duration of soft tissue numbness following the use of local dental anesthetic is 3-5 hours.  Numbness can lead to functional deficits.  These deficits can result in difficulty with speaking, smiling, eating, drinking, biting of the lip and cheek and uncontrolled drooling, as well as give the patient a perceived sense of altered appearance.  OraVerse has been proven to return a patient’s normal sensation twice as fast.

OraVerse has an excellent safety profile.  There are no contraindications and no known drug interactions with OraVerse.  In clinical trials, there were no significant differences in adverse events versus control groups.

If you are interested in getting back to your daily routine with full sensation and no lingering numbness after dental treatment, ask Dr. Smith and his staff about OraVerse.